StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by Liked2Thinkon Apr 01, 2021 9:56am

141 Views

Post# 32922010

All About Aristotle

He said it himself

"everyone knows about it"

:we have been talking about it for a long time"

So all that build up and when it is finally released they just gloss over it???

WTF

I was behind the guy but its obvious this company needs a charismatic news presenter of some sort. He. sounds like Biden bumbling throw a speach whie reading notes.

should had been 3 NRs to send this to the moon
1. Aristotle Officially announced partnered with the oncology company with some info about that company
2. Q4 financials NR release
3. NR about the health clinics

that would had been the proper way

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing